A new method of demonstrating the effect of therapy in von Willebrand's disease
Sutor, A.H.; Bowie, E.J.; Owen, C.A.
Mayo Clinic Proceedings 46(5): 345-346
1971
ISSN/ISBN: 0025-6196 PMID: 5314172 Document Number: 32280
Document emailed within 1 workday
Related Documents
Fukui, H.; Okuda, T.; Takase, T.; Mikami, S.; Yoshioka, A.; Fujimura, Y.; Yoshioka, K. 1978: Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(5): 897-907Inbal, A.; Kornbrot, N.; Harrison, P.; Randi, A.M.; Sadler, J.E. 1993: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor Thrombosis and Haemostasis 70(6): 1058-1062
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Fukui, H.; Yoshioka, A.; Mikami, S.; Takase, T.; Fujimura, Y.; Takahashi, Y.; Nishino, M.; Iwagaki, K. 1979: Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(6): 839-850
Piao, Y.C.; Lavergne, J.M.; Boyer-Neumann, C.; Schandelong, A.; Alessi, M.C.; Meyer, D. 1993: Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 4(5): 787-789
Nichols, T.C.; Bellinger, D.A.; Reddick, R.L.; Read, M.S.; Koch, G.G.; Brinkhous, K.M.; Griggs, T.R. 1991: Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs Circulation 83(6): Iv56-Iv64
Takahashi, H. 1981: Studies on the pathophysiology and treatment of von Willebrand's disease. II. Gel filtration studies on plasma factor VIIi in von Willebrand's disease Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(1): 165-172
Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Foster, P.A. 1995: The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 74(2): 784-790
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Sultan, Y.; Simeon, J.; Caen, J.P. 1976: Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease Journal of Laboratory and Clinical Medicine 87(2): 185-194
Lethagen, S.; Isaksson, C.; Schaedel, C.; Holmberg, L. 2002: Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X) Thrombosis and Haemostasis 88(3): 421-426
Girma, J.P.; Pietu, G.; Lavergne, J.M.; Meyer, D.; Larrieu, M.J. 1982: Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease Journal of Laboratory and Clinical Medicine 99(4): 481-494
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Sokolov, E.I.; Grishina, T.I.; Shtin, S.R. 2013: Effect of von Willebrand factor and endothelin-1 on formation of thrombotic status in patients with ischemic heart disease Kardiologiia 53(3): 25-30
Petkova, K.; Dilovski, M.; Bŭchvarova, I. 1986: A method for demonstrating mycoplasmas Veterinarno-Meditsinski Nauki 23(8): 47-50
Meyer, D.; Obert, B.; Pietu, G.; Lavergne, J.M.; Zimmerman, T.S. 1980: Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease Journal of Laboratory and Clinical Medicine 95(4): 590-602
Voigt, H.U.; Müller, H.; Fanger, K.; Klapper, W. 1974: A modified method for demonstrating H-phases in salmonellae Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 20(8): 497-498
Barczyk, A. 1992: A method for demonstrating chromosomes from human sperm and its application Ginekologia Polska 63(5): 240-245
Dyskin, E.A.; Mefodovskaia, T.M.; Moiseeva, M.L.; Tikhonova, L.P. 1976: Study of the microcirculatory bed by a method of demonstrating lactate dehydrogenase Arkhiv Anatomii Gistologii i Embriologii 71(11): 105-108